The frequency of infections with multiply antibiotic-resistant gram-positive bacteria is increasing, and in some cases these organisms remain susceptible only to the glycopeptides vancomycin and teicoplanin. The appearance of transferable high-level glycopeptide resistance in enterococciproducing some strains that are now resistant to all available antibiotics -is thus a cause for concern. The enterococci readily colonize the bowel, spread rapidly among hospital patients, and transfer their antibiotic resistances widely among themselves and other gram-positive species. Glycopeptide resistance has not yet transferred in vivo to other significant pathogens, but experimental transfer to Staphylococcus aureus has been achieved in vitro. The emergence of glycopeptideresistant enterococci has been encouraged by the increasing use of aminoglycosides, cephalosporins, and quinolones for the treatment of infections due to gram-negative bacteria and glycopeptides for infections due to staphylococci and Clostridium difficile. In Europe this antibiotic pressure has been aggravated by the use of the glycopeptide avoparcin in animal feeds. The enterococci may now be poised to disseminate glycopeptide resistance among other more pathogenic gram-positive bacteria.
The VanA resistance phenotype has been the most thoroughly transposon is flanked by inverted repeats IR L and IR R . Although usually encoded on a plasmid, the transposon has, in some studied [11, 12] . Vancomycin MICs range from 64 mg/L to ú1,024 mg/L, and teicoplanin MICs are usually one-or twofold cases, transferred to the chromosome [37] . A recently discovered transposon, Tn5482, consisting of Tn1546 and insertion lower. VanA resistance has been seen so far only in clinical isolates of enterococci, most frequently in E. faecium, sometimes sequences IS1251, can transfer vanA from the chromosome of one enterococcus to another [38] . in E. faecalis, and rarely in Enterococcus avium, Enterococcus durans, and some other enterococcal species [11, 12, [18] [19] [20] [21] [22] .
The mechanisms and genetics of the other vancomycin resistance phenotypes have not been so well elucidated, but they VanA resistance is usually inducible by subinhibitory concentrations of both vancomycin and teicoplanin and is associated with all seem to result from the production of altered ligases. The VanB phenotype is encoded by a similar gene cluster [39, 40] the production of a 38-40-kD membrane protein called VanA [23, 24] and encoded by the vanA gene [25, 26] .
encoded on a transposon Tn1547 and containing the vanB gene. The gene product VanB encodes a ligase that has a 76% amino The deduced amino acid sequence of VanA indicates that it is related to the bacterial D-Ala:D-Ala ligases, which mediate the acid identity with VanA [39] and is presumably responsible for the formation of D-Ala-D-Lac [41, 42] . Enterococci expressing D-alanyl-D-alanine (D-Ala-D-Ala) linkages of the growing cell wall peptidoglycan [26] . VanA appears to be a D-Ala:D-X ligase VanB are resistant to vancomycin but remain susceptible to teicoplanin, presumably because teicoplanin does not induce of relaxed substrate specificity that can condense D-alanine with other amino acids, fatty acids, or hydroxy acids [27] [28] [29] [30] . In resistance [40] . vanB can self-transfer between enterococci by conjugation, with the genetic material usually moving directly resistant organisms, D-Ala-D-Ala is replaced with D-Ala-D-lactate (D-Lac), which cannot bind glycopeptides [30] [31] [32] .
between the chromosomes [14, 38] . [30, 33] . VanX is a D, D-dipeptidase that destroys any D-Ala-D-Ala bonds produced by the normal bacterial ligase.
The emergence of the vanA cluster, with its cooperative genes arranged in perfect functional sequence, is surprising, In vancomycin-resistant E. faecalis and E. faecium, the genes encoding these proteins are located on a plasmid and arranged and attempts have been made to determine where this transposon might have come from. However, further analysis only sequentially within an operon. Induction of resistance is mediated by the transcription activator vanR and the membrane sensor deepens the mystery. Genetic probes for vanA hybridyze with DNA from enterococcal strains with the VanA phenotype but vanS, located upstream of the other members of the gene cluster [34] . The vanA operon may have evolved as part of a system of not with strains showing low-level (VanB) resistance, nor with E. gallinarum that shows the VanC phenotype or with DNA nutritional adaptability. In this model, membrane sensors (NtrB, EnvZ, PhoR, and VanS) detect changes in environmental concenfrom the organisms that produce vancomycin and teicoplanin, Amycolatopsis orientalis and Actinoplanes teichomyceticus trations (of nitrogen, osmolality, phosphate, and vancomycin/Dalanine) and switch on response regulators (NtrC, OmpR, PhoB, [27] . VanB and VanC also appear to be ligases, but they have only a 76% and 38% amino acid homology, respectively, with and VanR) to activate operons that enable alternative nutritional pathways [35] iodine are also unreliable agents, but alcohol and alcoholic chlorhexidine are effective [67, 68] . Hospital staff are notoribut they share genetic homology [27, 49] .
ously poor at hand washing and shun alcoholic preparations that cause chapped skin. It is likely, therefore, that hand transfer Enterococci Are Increasingly Common Causes of is a major route of enterococcal cross-infection. Evidence for Hospital-Acquired Infection this is provided by the isolation of outbreak strains of VRE and VSE from environmental surfaces with likely hand contact, Enterococci colonize the bowels of ú90% of healthy huincluding telephones, stethoscopes, bedrails, countertops, mans, and are found in counts of up to 10 7 cfu/g of stool [50, thermometer handles, bedpans, blood pressure cuffs, pulse-51]. E. faecalis is much more common than E. faecium, and oximeter couplings, instrument dials, and door knobs [62, 64, the other 16 species of enterococci are found only rarely. 69 -73] . Boyce et al. [64] found that during an outbreak of E. faecalis accounts for Ç90% of enterococcal isolates in clinienterococci carrying transferable VanB resistance, there was cal specimens, but in recent years E. faecium has become more extensive contamination of the environment, which was sigcommon, probably because of its greater antibiotic resistance nificantly more widespread around colonized patients who also [52, 53] . Most clinical isolates of enterococci represent colonihad diarrhea. zation rather than infection. They are often found in association Enterococci may survive for £7 days in the environment with other more virulent organisms, and the most common site [72] and may then be a further source of cross-infection. The of isolation is the urinary tract. However, enterococci can cause recovery of environmental isolates depends on culture methods, more-invasive infection and are sometimes responsible for choand the results must be interpreted with care. Nevertheless, lecystitis, cholangitis, peritonitis, septicemia, endocarditis, and some studies [38, 63, 65, 74] have failed to find epidemic meningitis, as well as simple wound infections [52, 53] .
strains of enterococci in the hospital environment, and in many For the last two decades, enterococci have been the third outbreaks these organisms may not be a major source of crossmost common cause of hospital-acquired infections (HAI) after infection. The detection of environmental contamination may Escherichia coli and S. aureus and ahead of Pseudomonas be related to the availability of single rooms for isolation, aeruginosa [54, 55] . Enterococci are becoming more common nursing and domestic cleaning practices, whether or not a paand are responsible for 10% -12% of all HAIs, 10% -20% tient has diarrhea, the resistance of the outbreak strains to of hospital-acquired urinary tract infections, and 5% -10% of drying, and the methods used for environmental screening. hospital-acquired bacteremias [55, 56] .
The reservoir for enterococci is the bowel, and most infections are endogenous. Thus, the increasing isolation rate for Enterococci Are Inherently Antibiotic Resistant and enterococci is usually caused by multiple endogenous strains Increasingly Multiresistant rather than outbreaks of cross-infection. Nevertheless, epidemic infection does occur, and organisms are probably spread from Enterococci are inherently more antibiotic resistant than other clinically important gram-positive bacteria and readily patient to patient on the hands of hospital staff [57 -60] .
During outbreaks of both vancomycin-susceptible (VSE) and acquire additional resistances (table I) . They are more resistant to penicillin than the streptococci because of the low affinity VRE, there is extensive colonization of the bowels of patients and staff, and asymptomatic carriage may persist for months of their cell wall penicillin-binding proteins (PBPs) [75] . Finally, some strains of enterococci have acquired plasmidmediated high-level vancomycin resistance as described prehigher than MICs, and clinical therapy may not be bactericidal. For this reason, enterococcal endocarditis is usually treated viously. The gradual accumulation of multiresistance to the whole range of antibiotics normally active against gramwith the synergistic and bactericidal combination of ampicillin plus gentamicin. However, this therapy will not be effective positive bacteria has resulted in some clinical isolates of enterococci -especially E. faecium -that are resistant to all curfor the increasingly common strains with high-level aminoglycoside resistance.
rently available agents. Enterococci are usually clinically resistant to cephalosporins, including the newer related b-lactams such as imipenem. These Increasing Use of Antimicrobials Has Encouraged the organisms also have inherent low-level resistance to clindaEmergence of Multiresistant Enterococci and VRE mycin, aminoglycosides, and the quinolones, and co-trimoxazole is not bactericidal. The inherent low-level vancomycin
The increasing frequency with which enterococci are isolated in clinical specimens has corresponded with the increasing use resistance in E. gallinarum, E. casseliflavus, and E. flavescens has already been discussed. of antibiotics to which these organisms are naturally resistant. In particular, there has been a dramatic increase in the use of In addition to this natural low-level resistance, the enterococci readily acquire high-level resistance and resistance to other drugs.
cephalosporins and quinolones, largely directed against gramnegative bacteria, which has probably encouraged the emergence Many recent isolates of E. faecium are fully resistant to ampicillin by the production of additional low-affinity PBPs, and some of enterococci as nosocomial pathogens. It is difficult to prove this hypothesis, but the circumstantial evidence is convincing. For strains of E. faecalis produce a plasmid-encoded b-lactamase, similar to the penicillinase of S. aureus [76, 77] , but such strains example, many case-control studies have shown that nosocomial enterococcal infection is associated with prior antimicrobial therare usually uncommon in clinical material. Enterococci are thus increasingly resistant to b-lactams [78] . High-level aminoglycoapy, especially that with cephalosporins [81, 82] , and studies on new agents have repeatedly shown that superinfection with side resistance may be acquired by chromosomal mutation (altering the ribosomal binding site) or by acquisition of plasmids enterococci often occurs following therapy with b-lactams and related drugs (moxalactam, aztreonam, or imipenem) and quinoencoding aminoglycoside-modifying enzymes [79, 80] . Chloramphenicol resistance is also usually enzymatic and plasmid borne, lones (ciprofloxacin) [83] [84] [85] . The facts that E. faecium is inherently more resistant than and high-level erythromycin and clindamycin resistance is now commonly seen as a result of the widespread dissemination of E. faecalis and that E. faecium has greater ability to acquire resistance, especially to ampicillin, are probably responsible transposons encoding macrolide/lincosamide/streptogramin resistance. Tetracycline resistance is also common and is mediated for the increasing frequency of this organism as a cause of / 9c54$$au10 07-21-98 11:01:33 cida UC: CID HAI. Since ampicillin resistance in this species is usually not and in the community. This prompted these authors to investigate the distribution of VRE in nonhuman sources, and they due to b-lactamase production, the increasing use of b-lactam/ b-lactamase inhibitor combinations such as amoxicillin/clavufound 14 different ribotypes of VRE in raw sewage, farm animals (including a duck, a chicken, a turkey, a dog, and a lanic acid and ampicillin/sulbactam has probably also contributed to its growing importance.
pony, as well as a number of pigs), and uncooked shop-bought chickens [93] . All isolates had high-level vancomycin resisThere must have been an element of chance in the initial emergence of vancomycin resistance, but once the VanA plastance and contained the vanA gene. Klare et al. [94, 95] then reported finding similar VRE in sewage and pig and poultry mid appeared, its dissemination has been encouraged by increasing usage of glycopeptides. Evidence for this is shown by manure from farms in Germany where the glycopeptide avoparcin was used as a feed supplement but not from a poultry the fact that VRE most frequently cause outbreaks in special units (i.e., adult and neonatal intensive care units, hematologic farm where avoparcin was not used. They also found VRE in uncooked chickens delivered to their hospital kitchens. All and oncologic wards, and renal and liver transplantation units) where glycopeptides are widely used. There has also been a these organisms contained vanA, and they were of a variety of different molecular types. more general increase in glycopeptide use in many other areas. Although vancomycin has been available for many years, the Torres et al. [96] found vanA-mediated VRE in sewage in Spain, and, in an extensive series of studies in Denmark, availability of less toxic and cheaper drugs limited the use of this agent until Ç10 years ago. Since then, the use of glycopepAarestrup [97] found more VRE in poultry and pig farms where avoparcin feed supplements were used but not in farms where tides for the treatment of infections due to multiresistant grampositive bacteria has greatly increased, especially those due to such supplements were not being used. Molecular typing of these Danish isolates showed a wide range of types, but some staphylococci. Methicillin-resistant S. aureus is now widespread throughout the world as a cause of hospital-acquired were similar in both animals and humans. The relationship between avoparcin use in animals and the appearance of vancoand, increasingly, community-acquired infection, and vancomycin is the treatment of choice for invasive infection with mycin-resistant enterococci in humans has been reviewed in detail by Bates [98] . this organism [86] .
Coagulase-negative staphylococci have also become very The results from these European studies provide incontrovertible evidence that vanA-mediated VRE are widespread in common because of their ability to stick to plastic catheters and other devices [87] . In hospitals, Ç50% of coagulase-negative the community and flourish in the bowels of animals where avoparcin is used as a feed supplement. It is likely that some staphylococci are resistant to methicillin and other antibiotics [88, 89] , and this finding has encouraged clinicians to adminishuman isolates of VRE have originated from animal sources. The use of avoparcin appears to make a significant contribution ter vancomycin -sometimes unnecessarily -when catheterassociated sepsis is suspected. Inappropriate glycopeptide use to the antibiotic pressure on VRE, and Denmark banned its use in animals in May 1995. Avoparcin is not used as an animal has been further encouraged by the marketing of teicoplanin, which is nontoxic and therefore more readily used than vancofeed supplement in the United States, where VRE do not appear to arise in the community. mycin. Finally, oral vancomycin is widely used for the eradication of Clostridium difficile in suspected cases of pseudomembranous colitis, another nosocomial infectious disease whose Outbreaks of VRE frequency has increased markedly in the last decade [90] .
These general trends are well illustrated by the study of The first report of VRE expressing the VanA phenotype appeared in 1988 when Uttley and colleagues [21, 99] described Ena and colleagues [91] of intravenous vancomycin use in a university hospital over the 10-year period 1981 -1991. Vancoa large outbreak that affected 41 renal patients at Dulwich Hospital in South London between 1986 and 1988. Although mycin use increased 20-fold over this period, and the increase was almost linear. Use was primarily related to the presence of most isolates were E. faecium, some were E. faecalis, and some E. avium. The most common site of isolation was the urinary indwelling intravascular devices and was particularly common among hematology/oncology patients. About one-third of tract, but there were many deep infections, and eight patients had bacteremia. Around the same time, there were sporadic courses were given for prophylaxis, one-third for empirical therapy, and only one-third for specific therapy directed by isolations of similar organisms in Paris and Nancy, France: LeClerq et al. [18, 46] reported phenotypically distinct strains culture and susceptibility results.
of E. faecium from the stools of four leukemic patients; Shlaes and colleagues [19] isolated E. faecium from the blood and Glycopeptide Use in Animal Husbandry peritoneal abscess of a patient with peritonitis and E. faecalis from the urine of a patient with a recurrent urinary tract infecWhile investigating a hospital outbreak of a clone of vancomycin-resistant E. faecium in a renal unit in Oxford, United tion [20] ; in addition, Bingen and colleagues [100] isolated vancomycin-resistant E. faecium from the blood of one patient Kingdom, Jordens and colleagues [92] four wards of a pediatric hospital over a 17-month period begenes within both the hospital and the community. Because they are of low virulence and readily colonize the bowels of tween 1988 and 1990, but the isolates were all genetically distinct by restriction digest analysis.
humans and animals, asymptomatic carriers are common and can cause extensive contamination of the environment. Al-VRE appeared in New York City in 1989 [101] . The first isolate was reported in September 1989, and by October 1991, though it has not yet occurred in nature, there is a real danger that in the future vanA resistance will spread from enterococci resistant strains had been isolated from ú360 patients in at least 38 hospitals. Most isolates were E. faecium, and a few to staphylococci and pneumococci. The emergence of vancomycin-resistant, methicillin-resistant S. aureus now seems inwere E. faecalis. The great majority were hospital acquired, but two of the first 100 patients affected seem to have acquired evitable, and we face the prospect that serious and invasive staphylococcal infections may once more become untreatable. their infections in the community. Forty-two patients died, and vancomycin-resistant enterococcal infection was believed to
There is thus an urgent need to reduce the antibiotic pressure that encourages such resistance and to limit the spread of the have contributed to 19 of these deaths. Among ity. In addition to clinical cases, screening has revealed many 5. Orberg PK, Sandine WE. 
